Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss
Efficacy of 3% Minoxidil Versus Combined 3% Minoxidil and 0.1% Finasteride for Male Pattern Hair Loss: a Randomized, Double-blinded, Comparative Study
In the register
The register attaches this trial to Minoxidil (topical), currently at “Approved” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Completed
- Declared phase
- Phase 3
- Sponsor
- Mae Fah Luang University Hospital
- Participants (registry)
- 40
- Start
- March 2011
- Primary completion
- March 2012
- Study completion
- March 2012
- Last registry update
- July 2012
- Countries
- Thailand
Conditions studied: Androgenetic Alopecia
Interventions: 3%Minoxidil lotion, 3% Minoxidil with 0.1% Finasteride lotion
Other trials of Minoxidil (topical)
Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.
- NCT07901426Active, not recruiting
Evaluation of the Scalp Skin Care Effects of Premium Revitalizing Elixir and Topical 5% Minoxidil
Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia
Efficacy & Safety of Minoxidil SL Tablets in Men With AGA
- NCT07056933Not yet recruiting
Effect of Minoxidil Solution Iontophoresis on Androgenic Alopecia
Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia
Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia
Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia
Treatment of Androgenetic Alopecia in Men for 24 Weeks
Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.